Medicine
Chlorthalidone 50 mg tablet
Chlorthalidone 50 mg tablet is a generic prescription medicine for oral use, made by 25 labelers, with its source record on the US FDA register. It is available on request for export supply from India to licensed hospitals, importers and physicians.
Availability
Export supply from India to licensed buyers
Typical lead time
On request
Counted from payment and complete documents
Shipping
Ambient
Store at 20° to 25°C (68° to 77°F). Protect from light.
Key facts
- Active ingredient (INN)
- Chlorthalidone
- Brand
- Sold under the generic name
- Strength
- 50 mg
- Dosage form
- Tablet
- Route
- Oral
- Packs
- 100 tablets, 90 tablets, 1000 tablets and 68 more
- Manufacturers
- Alembic PharmaceuticalsIndiaAscend LaboratoriesIndiaDr. Reddy's LaboratoriesIndiaIpca LaboratoriesIndiaMacleods PharmaceuticalsIndiaZydus LifesciencesIndiaLifestar PharmaIndiaSun Pharmaceutical IndustriesIndiaUmedica LaboratoriesIndiaUnichem LaboratoriesIndia25 labelers on the register
- Origin register
- US FDA, United States
- Storage
- Store at 20° to 25°C (68° to 77°F). Protect from light.
- Cold chain
- Not required on record
- Prescription status
- Prescription only
- Controlled substance
- Not recorded as controlled
- ATC code
- C03BA04 Chlorthalidone
- HS code (indicative)
- 3004.90Indicative only. Your customs broker confirms the final tariff code.
- Marketing category
- marketed
- Marketed since
- 26 February 1981
- Identifiers
- RxCUI 197500, 197499DailyMed set ID a73613a3-914f-481a-8e40-8d782bcea03a, 9e9e9ced-6960-4d2f-bb23-ef8b2435da75, 1b98d1a1-9d3d-41d2-a5e9-744b851d30d4 +36NDC 71335-3089, 43598-720, 46708-677 +36Application ANDA211627, ANDA210742, ANDA216262 +14
Record updated 12 November 2026
Documents available
Documents that can be provided with this medicine. Your regulator may ask for more, and the quote lists the full set.
No document list is recorded for this medicine yet. Tell us which documents your regulator needs (for example a CoA, COPP or GMP certificate) when you request a quote.
Packs
A sample of 40 packs from 25 labelers. The register lists 71 packs for this generic presentation, and we confirm the exact pack on the quote.
| Pack | Code | Labeler | Marketed since |
|---|---|---|---|
| 100 tablet in 1 bottle | 46708-677-31 | Alembic PharmaceuticalsIndia | 29 August 2022 |
| 90 tablet in 1 bottle | 46708-677-90 | Alembic PharmaceuticalsIndia | 29 August 2022 |
| 1000 tablet in 1 bottle | 46708-677-91 | Alembic PharmaceuticalsIndia | 29 August 2022 |
| 100 tablet in 1 bottle | 62332-677-31 | Alembic PharmaceuticalsIndia | 29 August 2022 |
| 90 tablet in 1 bottle | 62332-677-90 | Alembic PharmaceuticalsIndia | 29 August 2022 |
| 1000 tablet in 1 bottle | 62332-677-91 | Alembic PharmaceuticalsIndia | 29 August 2022 |
| 100 tablet in 1 bottle | 43598-167-01 | Dr. Reddy's LaboratoriesIndia | 20 October 2022 |
| 1000 tablet in 1 bottle | 43598-167-10 | Dr. Reddy's LaboratoriesIndia | 20 October 2022 |
| 100 tablet in 1 bottle | 43598-720-01 | Dr. Reddy's LaboratoriesIndia | 23 October 2018 |
| 1000 tablet in 1 bottle | 43598-720-10 | Dr. Reddy's LaboratoriesIndia | 9 December 2021 |
| 100 tablet in 1 bottle | 68382-971-01 | Zydus LifesciencesIndia | 15 May 2019 |
| 1000 tablet in 1 bottle | 68382-971-10 | Zydus LifesciencesIndia | 15 May 2019 |
| 1000 tablet in 1 bottle | 70771-1370-0 | Zydus LifesciencesIndia | 15 May 2019 |
| 100 tablet in 1 bottle | 70771-1370-1 | Zydus LifesciencesIndia | 15 May 2019 |
| 100 tablet in 1 bottle | 27241-217-01 | Ajanta PharmaIndia | 20 May 2021 |
| 100 tablet in 1 bottle | 67877-697-01 | Ascend LaboratoriesIndia | 13 February 2020 |
| 1000 tablet in 1 bottle | 67877-697-10 | Ascend LaboratoriesIndia | 13 February 2020 |
| 1 blister pack in 1 carton / 10 tablet in 1 blister pack | 67877-697-33 | Ascend LaboratoriesIndia | 13 February 2020 |
| 10 blister pack in 1 carton / 10 tablet in 1 blister pack | 67877-697-38 | Ascend LaboratoriesIndia | 13 February 2020 |
| 100 tablet in 1 bottle | 83980-062-01 | Ipca LaboratoriesIndia | 21 September 2026 |
| 1000 tablet in 1 bottle | 83980-062-10 | Ipca LaboratoriesIndia | 21 September 2026 |
| 30 tablet in 1 bottle | 83980-062-13 | Ipca LaboratoriesIndia | 21 September 2026 |
| 90 tablet in 1 bottle | 83980-062-19 | Ipca LaboratoriesIndia | 21 September 2026 |
| 100 tablet in 1 bottle | 59746-761-01 | Jubilant Cadista Pharmaceuticals,incIndia | 31 March 2021 |
| 100 tablet in 1 bottle | 70756-020-11 | Lifestar PharmaIndia | 5 August 2022 |
| 1000 tablet in 1 bottle | 70756-020-12 | Lifestar PharmaIndia | 5 August 2022 |
| 30 tablet in 1 bottle | 33342-426-07 | Macleods PharmaceuticalsIndia | 1 July 2026 |
| 90 tablet in 1 bottle | 33342-426-10 | Macleods PharmaceuticalsIndia | 1 July 2026 |
| 100 tablet in 1 bottle | 33342-426-11 | Macleods PharmaceuticalsIndia | 1 July 2026 |
| 1000 tablet in 1 bottle | 33342-426-44 | Macleods PharmaceuticalsIndia | 1 July 2026 |
| 1000 tablet in 1 bottle | 57664-649-18 | Sun Pharmaceutical IndustriesIndia | 4 November 2022 |
| 100 tablet in 1 bottle | 57664-649-88 | Sun Pharmaceutical IndustriesIndia | 12 February 2016 |
| 100 tablet in 1 bottle | 60290-005-01 | Umedica LaboratoriesIndia | 15 February 2026 |
| 1000 tablet in 1 bottle | 60290-005-02 | Umedica LaboratoriesIndia | 15 February 2026 |
| 100 tablet in 1 bottle, plastic | 29300-334-01 | Unichem LaboratoriesIndia | 1 October 2019 |
| 1000 tablet in 1 bottle, plastic | 29300-334-10 | Unichem LaboratoriesIndia | 1 October 2019 |
| 100 tablet in 1 bottle, plastic | 64980-304-01 | Rising Pharma Holdings | 17 May 2017 |
| 100 tablet in 1 bottle | 64980-600-01 | Rising Pharma Holdings | 23 October 2024 |
| 30 tablet in 1 bottle | 65162-250-03 | Amneal Pharmaceuticals | 1 July 2019 |
| 90 tablet in 1 bottle | 65162-250-09 | Amneal Pharmaceuticals | 1 July 2019 |
Status by register
Where this medicine is registered, from the source record and the regulator data we hold. Ask us about a country that is not listed.
| Register | Status | Source |
|---|---|---|
| US FDA | Listed, marketed | Source record for this pageChecked 12 November 2026 |
| US FDA | First approved 7 April 1960 | Drugs@FDA |
| EU (EMA) | Not recorded | — |
| India (CDSCO) | Not yet confirmed against CDSCO approval lists | — |
| United States | Registered | US FDA (NDC directory, openFDA)Checked 12 November 2026 |
Import route
Pick the destination country to see the legal import route, who applies and typical timelines, from our import guide for that country.
Import guides are available for 25 countries. Pick one to see its route summary.
BrazilColombiaEgyptEthiopiaGhanaIraqKazakhstanKenyaAll import guides
Other strengths and forms of Chlorthalidone
Clinical summary
Chlorthalidone is a thiazide-like diuretic indicated for the treatment of hypertension, to lower blood pressure, among other approved uses. It is available as tablets for oral use. MedsAcross supplies Chlorthalidone for export from India to licensed hospitals, importers and physicians acting for named patients, with the documents each country requires.
Information from the US FDA prescribing information, retrieved 12 November 2026. Not yet medically reviewed.How we review
Read about ChlorthalidoneFor healthcare professionals and buyers. This is not medical advice. Treatment decisions belong to the prescriber.
Data sources
- DailyMed label record · Checked 12 November 2026
- Thalitone prescribing information (Casper Pharma) · U.S. National Library of Medicine, DailyMed
Need Chlorthalidone 50 mg tablet for your hospital or patient?
Send one request with the destination country and quantity. We confirm availability, lead time and the documents your regulator needs.